Blog
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Jazz Pharmaceuticals (JAZZ) reports results for the quarter ended March 2025. While this widely-known consensus
Will Lucid Group (LCID) Report Negative Earnings Next Week? What You Should Know
Wall Street expects a year-over-year increase in earnings on higher revenues when Lucid Group (LCID) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy?
Krystal Biotech, Inc. (KRYS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Analysts Estimate J&J Snack Foods (JJSF) to Report a Decline in Earnings: What to Look Out for
The market expects J&J Snack Foods (JJSF) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Earnings Preview: IPG Photonics (IPGP) Q1 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when IPG Photonics (IPGP) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Ingredion (INGR) Earnings Expected to Grow: Should You Buy?
The market expects Ingredion (INGR) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook
Intapp (INTA) Earnings Expected to Grow: Should You Buy?
The market expects Intapp (INTA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Analysts Estimate International General Insurance Holdings Ltd. (IGIC) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when International General Insurance Holdings Ltd. (IGIC) reports results for the quarter ended March 2025. While this
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Heron Therapeutics (HRTX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Forrester Research (FORR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Wall Street expects a year-over-year decline in earnings on lower revenues when Forrester Research (FORR) reports results for the quarter ended March 2025. While this widely-known consensus outlook
Will Forge Global Holdings, Inc. (FRGE) Report Negative Q1 Earnings? What You Should Know
Forge Global Holdings, Inc. (FRGE) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known
Analysts Estimate Helios Technologies (HLIO) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on lower revenues when Helios Technologies (HLIO) reports results for the quarter ended March 2025. While this widely-known consensus outlook
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Halozyme Therapeutics (HALO) reports results for the quarter ended March 2025. While this widely-known consensus
Will Genius Sports Limited (GENI) Report Negative Earnings Next Week? What You Should Know
Genius Sports Limited (GENI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Analysts Estimate Datadog (DDOG) to Report a Decline in Earnings: What to Look Out for
The market expects Datadog (DDOG) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Earnings Preview: Fortune Brands Innovations (FBIN) Q1 Earnings Expected to Decline
The market expects Fortune Brands Innovations (FBIN) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known
Expeditors International (EXPD) Earnings Expected to Grow: Should You Buy?
The market expects Expeditors International (EXPD) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known
Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
The market expects Esperion Therapeutics (ESPR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known
Enlight Renewable Energy Ltd. (ENLT) Earnings Expected to Grow: Should You Buy?
The market expects Enlight Renewable Energy Ltd. (ENLT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This
Coty (COTY) Reports Next Week: What You Should Expect
Coty (COTY) is expected to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook
Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know
The market expects Caribou Biosciences, Inc. (CRBU) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known
Corpay (CPAY) Earnings Expected to Grow: Should You Buy?
The market expects Corpay (CPAY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Coupang, Inc. (CPNG) Earnings Expected to Grow: Should You Buy?
The market expects Coupang, Inc. (CPNG) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
The market expects Apellis Pharmaceuticals, Inc. (APLS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This
Chord Energy Corporation (CHRD) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Wall Street expects a year-over-year decline in earnings on higher revenues when Chord Energy Corporation (CHRD) reports results for the quarter ended March 2025. While this widely-known consensus